Royal Society of Chemistry, Chemical Science, 30(14), p. 8054-8060, 2023
DOI: 10.1039/d3sc02513f
Full text: Download
We developed 211At-radiolabeled 2,6-diisopropylphenyl azide (ADIPA) for targeted α-particle therapy. In the experiment using a mouse model, low-dose (70 kBq) administration of ADIPA effectively suppressed tumor growth without causing adverse effects.